VEGF-A and -C but not -B mediate increased vascular permeability in preserved lung grafts

Transplantation

Volumn 73, Issue 11, 2002, Pages 1703-1706

  Abraham, Dietmar ^a   Taghavi, Shahrokh ^a   Riml, Patricia ^a   Paulus, Patrick ^a   Hofmann, Michael ^a   Baumann, Claudia ^a   Kocher, Alfred ^a   Klepetko, Walter ^a   Aharinejad, Seyedhossein ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL GROWTH; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; GRAFT PRESERVATION; HYPOXIA; IMMUNOCYTOCHEMISTRY; LUNG BIOPSY; LUNG EDEMA; LUNG INJURY; LUNG TRANSPLANTATION; LUNG WEIGHT; MEASUREMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECIPIENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 0037096659     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200206150-00003     Document Type: Article

References (31)

1. Molecular and biological properties of vascular endothelial growth factor
2. Vascular endothelial growth factor gene expression in human fetal lung in vitro
3. Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension
4. VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivo
5. Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart
6. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization
7. Differences in myocardial and peripheral VEGF and KDR levels after acute ischemia
8. Increased expression of KDR/Flk-1 (VEGFR-2) in murine model of ischemia-induced retinal neovascularization
9. VEGF fetal liver kinase-1, and permeability increase during unilateral lung ischemia
10. Beneficial effect of iloprost on early pulmonary function after lung preservation with modified Euro-Collins solution
11. Preservation for clinical lung transplantation
12. Comparison between mycophenolate mofetil- and azathioprine-based immunosuppressions in clinical lung transplantation
13. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
14. Selective downregulation of VEGF-A165, VEGF-R1, and decreased capillary density in patients with dilative but not ischemic cardiomyopathy
15. Lung preservation: The importance of endothelial and alveolar type II cell integrity
16. Lung transplantation
17. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors
18. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor
19. The biology of vascular endothelial growth factor
20. Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema
21. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia
22. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes
23. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo
24. Regulation of VEGF expression in cultured keratinocytes: Implications for normal and impaired wound healing
25. Preventive effect of inhaled nitric oxide and pentoxifylline on ischemia/reperfusion injury after lung transplantation
26. Translation of vascular endothelial growth factor mRNA by internal ribosome entry: Implications for translation under hypoxia
27. Cyclosporine, FK506, mycophenolate mofetil, and prednisolone differentially modulate cytokine gene expression in human airway-derived epithelial cells
28. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
29. A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities
30. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C
31. Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection